Abstract
Emphysema is a form of chronic obstructive pulmonary disease (COPD), that is defined by the Global Initiative for chronic obstructive lung disease (GOLD). It is a disease that affects the air spaces distal to the terminal bronchiole, and further characterized by abnormal permanent dilation of the air spaces. This leads to destruction of these air spaces and lung parenchyma with loss of elasticity.
Cystic lung disease has a broad differential diagnosis, which includes Alpha 1-Antitrypsin deficiency, Birt-Hogg-Dube syndrome, and Lymphoid interstitial pneumonia, to name a few. Pathophysiological development of these various diseases varies from airway obstruction to remodeling of the lung, which leads to cystic development. An accurate diagnosis can be challenging, and management is dependent on the disease. A combination of imaging, serum tests, genetic tests, and clinical features can aid in differentiating between various etiologies. A biopsy is often required for definitive diagnosis. This chapter presents an overview of Emphysema, as well as various Cystic Lung Diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fernandez-Bussy S, Labarca G, Herth FJF. Bronchoscopic lung volume reduction in patients with severe emphysema. Semin Respir Crit Care Med. 2018;39(6):685–92.
Zhang H, Dong L, Kang YK, Lu Y, Wei HH, Huang J, Wang X, Huang K. Epidemiology of chronic airway disease: results from a cross-sectional survey in Beijing, China. J Thorac Dis. 2018;10(11):6168–75.
Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease [published correction appears in J Clin Invest. 2012 Nov;122(11):4300]. J Clin Invest. 2012;122(8):2749–55. https://doi.org/10.1172/JCI60324.
Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008;5(4):475–7. https://doi.org/10.1513/pats.200708-126ET.
Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365(9478):2225–36.
Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD Gene study. Am J Respir Crit Care Med. 2011;184(4):414–20.
Tan WC, Lo C, Jong A, et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180(8):814–20.
Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718.
Balkissoon R. Journal club-COPD2020 update. Global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD Foundation special edition, moving to a new definition for COPD: “COPDGene2019”. Chronic Obstr Pulm Dis. 2020;7(1):64–72.
Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–66. https://doi.org/10.1056/NEJMra1900500.
Buttar BS, Bernstein M. The importance of early identification of Alpha-1 antitrypsin deficiency. Cureus. 2018;10(10):e3494. PMID: 30648036; PMCID: PMC6318138. https://doi.org/10.7759/cureus.3494.
Bhatt SP, Bhakta NR, Wilson CG, Cooper CB, Barjaktarevic I, Bodduluri S, Kim YI, Eberlein M, Woodruff PG, Sciurba FC, Castaldi PJ, Han MK, Dransfield MT, Nakhmani A. New spirometry indices for detecting mild airflow obstruction. Sci Rep. 2018;8(1):17484.
Sharma N, Justaniah AM, Kanne JP, Gurney JW, Mohammed TL. Vanishing lung syndrome (giant bullous emphysema): CT findings in 7 patients and a literature review. J Thorac Imaging. 2009;24(3):227–30. https://doi.org/10.1097/RTI.0b013e31819b9f2a.
Stern EJ, Frank MS. CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR Am J Roentgenol. 1994;162(4):791–8.
Papi A, Vestbo J, Fabbri L, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391:1076–84.
Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689–98.
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–82.
Tiong LU, Davies R, Gibson PG, et al. Lung volume reduction surgery for diffuse emphysema. Cochrane Database Syst Rev. 2006;(4):CD001001.
Hersh CP, Campbell EJ, Scott LR, Raby BA. Alpha-1 antitrypsin deficiency as an incidental finding in clinical genetic testing. Am J Respir Crit Care Med. 2019;199(2):246–8.
McCarthy C, Lara Gallego B, Trapnell BC, McCormack FX. Epidemiology of rare lung diseases: the challenges and opportunities to improve research and knowledge. Adv Exp Med Biol. 2017;1031:419–42.
Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–55. https://doi.org/10.1056/NEJMra1910234.
Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360(26):2749–57. https://doi.org/10.1056/NEJMcp0900449.
Ledoux-Corbusier M, Achten G. Alpha1-antitrypsin deficiency and skin abnormalities. J Cutan Pathol. 1975;2(1):25–9. https://doi.org/10.1111/j.1600-0560.1975.tb00827.x.
Stone HM, Edgar RG, Thompson RD, Stockley RA. Lung transplantation in Alpha-1-antitrypsin deficiency. COPD. 2016;13(2):146–52. Epub 2015 Oct 21. https://doi.org/10.3109/15412555.2015.1048850.
Marziali V, Geropoulos G, Frasca L, Longo F, Patrini D, Panagiotopoulos N, Crucitti P. Focus on the pulmonary involvement and genetic patterns in Birt-Hogg-Dubè syndrome: literature review. Respir Med. 2020;168:105995. Epub 2020 May 6. https://doi.org/10.1016/j.rmed.2020.105995.
Daccord C, Good J-M, Morren M-A, Bonny O, Hohl D, Lazor R. Eur Respir Rev. 2020;29(157):200042.
Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, Nordenskjöld M, Hansen TV, Solly J, Maher ER, European BHD Consortium. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009;10(12):1199–206. https://doi.org/10.1016/S1470-2045(09)70188-3.
Daccord C, Cottin V, Prévot G, Uzunhan Y, Mornex JF, Bonniaud P, Orpha Lung Network. Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients. Orphanet J Rare Dis. 2020;15:1–8.
Tobino K, Gunji Y, Kurihara M, Kunogi M, Koike K, Tomiyama N, Johkoh T, Kodama Y, Iwakami S, Kikkawa M, Takahashi K, Seyama K. Characteristics of pulmonary cysts in Birt-Hogg-Dubé syndrome: thin-section CT findings of the chest in 12 patients. Eur J Radiol. 2011;77(3):403–9. Epub 2009 Sep 25. https://doi.org/10.1016/j.ejrad.2009.09.004.
Kumasaka T, Hayashi T, Mitani K, Kataoka H, Kikkawa M, Tobino K, Kobayashi E, Gunji Y, Kunogi M, Kurihara M, Seyama K. Characterization of pulmonary cysts in Birt-Hogg-Dubé syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients. Histopathology. 2014;65(1):100–10. Epub 2014 Mar 4. PMID: 24393238; PMCID: PMC4237186. https://doi.org/10.1111/his.12368.
Bragg DG, Chor PJ, Murray KA, Kjeldsberg CR. Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features. AJR Am J Roentgenol. 1994;163(2):273–81. https://doi.org/10.2214/ajr.163.2.8037014.
Tanaka T, Ishida K. Update on rare idiopathic interstitial pneumonias and rare histologic patterns. Arch Pathol Lab Med. 2018;142(9):1069–79. https://doi.org/10.5858/arpa.2017-0534-RA.
Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J. 2006;28(2):364–9. Epub 2006 Mar 29. https://doi.org/10.1183/09031936.06.00076705.
Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J. 2002;19(5):794–6. https://doi.org/10.1183/09031936.02.00492002.
Honda O, Johkoh T, Ichikado K, et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol. 1999;173:71–4.
Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002;122(6):2150–64. https://doi.org/10.1378/chest.122.6.2150.
Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305(27):1617–27. https://doi.org/10.1056/NEJM198112313052704.
Zamora AC, Collard HR, Wolters PJ, Webb WR, King TE. Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J. 2007;29:210–4.
Ueda K, Honda O, Satoh Y, Kawai M, Gyobu T, Kanazawa T, Hidaka S, Yanagawa M, Sumikawa H, Tomiyama N. Computed tomography (CT) findings in 88 neurofibromatosis 1 (NF1) patients: prevalence rates and correlations of thoracic findings. Eur J Radiol. 2015;84(6):1191–5. Epub 2015 Mar 7. https://doi.org/10.1016/j.ejrad.2015.02.024.
Dehal N, Arce Gastelum A, Millner PG. Neurofibromatosis-associated diffuse lung disease: a case report and review of the literature. Cureus. 2020;12(6):e8916. Published 2020 Jun 29. https://doi.org/10.7759/cureus.8916.
Massaro D, Katz S. Fibrosing alveolitis: its occurrence, roentgenographic, and pathologic features in Von Recklinghausen’s neurofibromatosis. Am Rev Respir Dis. 1966;93:934–42. https://doi.org/10.1164/arrd.1966.93.6.934.
Cortini F, Villa C. Ehlers-Danlos syndromes and epilepsy: an updated review. Seizure. 2018;57:1–4.
Callewaert B, Malfait F, Loeys B, De Paepe A. Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol. 2008;22(1):165–89. https://doi.org/10.1016/j.berh.2007.12.005.
Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8–26. https://doi.org/10.1002/ajmg.c.31552.
Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77:31–7.
Shalhub S, Neptune E, Sanchez DE, Dua A, Arellano N, McDonnell NB, Milewicz DM. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome. Am J Med Genet A. 2019;179(5):797–802. Epub 2019 Feb 22. https://doi.org/10.1002/ajmg.a.61094.
Ruggeri P, Calcaterra S, Girbino G. Bullous emphysema as first presentation of Ehlers-Danlos syndrome in monozygotic twins. Respir Med Case Rep. 2014;14:40–2. Published 2014 Dec 24. https://doi.org/10.1016/j.rmcr.2014.12.002.
Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965–76.
Hoffjan S. Genetic dissection of Marfan syndrome and related connective tissue disorders: an update 2012. Mol Syndromol. 2012;3(2):47–58.
Neuville M, Jondeau G, Crestani B, Taillé C. Manifestations respiratoires du syndrome de Marfan [Respiratory manifestations of Marfan’s syndrome]. Rev Mal Respir. 2015;32(2):173–81. French. Epub 2014 Nov 6. https://doi.org/10.1016/j.rmr.2014.06.030.
Streeten EA, Murphy EA, Pyeritz RE. Pulmonary function in the Marfan syndrome. Chest. 1987;91:408–12.
Fraser S, Child A, Hunt I. Pectus updates and special considerations in Marfan syndrome. Pediatr Rep. 2018;9(4):7277. Published 2018 Jan 4. https://doi.org/10.4081/pr.2017.7227.
Sharma BK, Talukdar B, Kapoor R. Cystic lung in Marfan’s syndrome. Thorax. 1989;44(11):978–9. https://doi.org/10.1136/thx.44.11.978.
Karpman C, Aughenbaugh GL, Ryu JH. Pneumothorax and bullae in Marfan syndrome. Respiration. 2011;82(3):219–24. Epub 2011 Jan 22. https://doi.org/10.1159/000322958.
Limaïem, F., Ayadi-Kaddour, A., Djilani, H. et al. Pulmonary and mediastinal bronchogenic cysts: a clinicopathologic study of 33 cases. Lung 2008 186, 55–61.
Kirmani B, Kirmani B, Sogliani F. Should asymptomatic bronchogenic cysts in adults be treated conservatively or with surgery? Interact Cardiovasc Thorac Surg. 2010;11(5):649–59. Epub 2010 Aug 13. https://doi.org/10.1510/icvts.2010.233114.
Lardinois D, Gugger M, Ris HB. Bronchogenic cyst of the left lower lobe associated with severe hemoptysis. Eur J Cardiothorac Surg. 1999;16(3):382–3.
Mawatari T, Itoh T, Hachiro Y, Harada H, Kobayashi T, Saitoh T, Ohsawa H, Watanabe A, Abe T. Large bronchial cyst causing compression of the left atrium. Ann Thorac Cardiovasc Surg. 2003;9(4):261–3.
McAdams HP, Kirejczyk WM, Rosado-de-Christenson ML, Matsumoto S. Bronchogenic cyst: imaging features with clinical and histopathologic correlation. Radiology. 2000;217(2):441–6.
Chen TJ, Liao CH, Shen TC. Bronchogenic cyst. QJM. 2018;111(12):905.
Bolton JW, Shahian DM. Asymptomatic bronchogenic cysts: what is the best management? Ann Thorac Surg. 1992;53(6):1134–7. https://doi.org/10.1016/0003-4975(92)90412-w.
Lee DH, Park CK, Kum DY, Kim JB, Hwang I. Clinical characteristics and management of intrathoracic bronchogenic cysts: a single center experience. Korean J Thorac Cardiovasc Surg. 2011;44(4):279–84.
Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352(19):1992–2001. https://doi.org/10.1056/NEJMra043184.
Sanders DB, Fink AK. Background and epidemiology. Pediatr Clin North Am. 2016;63(4):567–84. https://doi.org/10.1016/j.pcl.2016.04.001.
Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ. 2007;335(7632):1255–9. https://doi.org/10.1136/bmj.39391.713229.AD.
Farrell PM, White TB, Ren CL, et al. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr. 2017;181S:S4–S15.e1. https://doi.org/10.1016/j.jpeds.2016.09.064.
Meyer CA, White CS, Sherman KE. Diseases of the hepatopulmonary axis. Radiographics. 2000;20(3):687–98.
Robbins SL, Kumar V, Abbas AK, et al. Robbins and Cotran pathologic basis of disease. Philadelphia: W.B. Saunders; 2010. ISBN:1416031219.
Stern M, Picard C, Roux A. Lung transplantation. Rev Prat. 2018;68(2):189–94.
Kapnadak SG, Dimango E, Hadjiliadis D, Hempstead SE, Tallarico E, Pilewski JM, Faro A, Albright J, Benden C, Blair S, Dellon EP, Gochenour D, Michelson P, Moshiree B, Neuringer I, Riedy C, Schindler T, Singer LG, Young D, Vignola L, Zukosky J, Simon RH. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros. 2020;19(3):344–54. Epub 2020 Feb 27. https://doi.org/10.1016/j.jcf.2020.02.015.
Lynch JP 3rd, Sayah DM, Belperio JA, Weigt SS. Lung transplantation for cystic fibrosis: results, indications, complications, and controversies. Semin Respir Crit Care Med. 2015;36(2):299–320. https://doi.org/10.1055/s-0035-1547347.
Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R, VX17-445-102 Study Group. Elexacaftor-Tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med. 2019;381(19):1809–19. Epub 2019 Oct 31. PMID: 31697873; PMCID: PMC7282384. https://doi.org/10.1056/NEJMoa1908639.
Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease, part II. Am J Respir Crit Care Med. 2015;192(1):17–29.
Durell J, Lakhoo K. Congenital cystic lesions of the lung. Early Hum Dev. 2014;90:935–9.
Stocker JT. Cogenital pulmonary airway malformation—a new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology. 2002;41:424.
Colombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, Mal H, Taille C, Monnet I, Fournier M, Herson S, Danel C. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173:777–80.
Rho L, Qui L, Strauchen JA, Gordon RE, Teirsten AS. Pulmonary manifestations of light chain deposition disease. Respirology. 2009;14:767–76.
Kijner C, Yousem S. Systemic light chain deposition disease presenting as multiple pulmonary nodules: a case report and review of the literature. Am J Surg Pathol. 1988;12(5):405–13.
Bhargava P, Rushin J, Rusnock E, et al. Pulmonary light chain deposition disease: report of five cases and review of the literature. Am J Surg Pathol. 2007;31(2):267–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jacob, S., Warner, M.T. (2023). Emphysema and Cystic Lung Disease. In: Moran, C.A., Truong, M.T., de Groot, P.M. (eds) The Thorax. Springer, Cham. https://doi.org/10.1007/978-3-031-21040-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-031-21040-2_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-21039-6
Online ISBN: 978-3-031-21040-2
eBook Packages: MedicineMedicine (R0)